Unknown

Dataset Information

0

Antiviral response in vernal keratoconjunctivitis may be protective against COVID-19.

ABSTRACT:

SUBMITTER: Leonardi A 

PROVIDER: S-EPMC8441822 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Antiviral response in vernal keratoconjunctivitis may be protective against COVID-19.

Leonardi Andrea A   Rosani Umberto U   Cavarzeran Fabiano F   Daull Philippe P   Garrigue Jean-Sebastien JS   Paola Brun B  

Allergy 20210821 1

Similar Datasets

Unknown Immunophenotyping in Vernal Keratoconjunctivitis: Schirmer Test for Therapy Response Prediction.
| S-EPMC12261867 | biostudies-literature
Unknown Endoplasmic Reticulum Stress and Unfolded Protein Response in Vernal Keratoconjunctivitis.
| S-EPMC11008754 | biostudies-literature
Unknown Diagnosis, Management, and Treatment of Vernal Keratoconjunctivitis in Asia: Recommendations From the Management of Vernal Keratoconjunctivitis in Asia Expert Working Group.
| S-EPMC9376221 | biostudies-literature
Unknown MicroRNA Profiling of the Tears of Children With Vernal Keratoconjunctivitis.
| S-EPMC9039132 | biostudies-literature
Unknown Air Pollution and Meteorological Conditions Significantly Associated With Vernal Keratoconjunctivitis Exacerbations.
| S-EPMC10382993 | biostudies-literature
Unknown Efficacy of montelukast in preventing seasonal recurrence of vernal keratoconjunctivitis in children.
| S-EPMC9046287 | biostudies-literature
Unknown Prevalence of allergic sensitization with vernal keratoconjunctivitis: A systematic review with meta-analyses.
| S-EPMC10084059 | biostudies-literature
Unknown Molnupiravir and Its Antiviral Activity Against COVID-19.
| S-EPMC9013824 | biostudies-literature
Unknown Dendritic Cell Density and Morphology Can Be Used to Differentiate Vernal Keratoconjunctivitis from Allergic Conjunctivitis.
| S-EPMC10605082 | biostudies-literature
Unknown Motivating Protective Behavior against COVID-19: Fear Versus Hope.
| S-EPMC9207583 | biostudies-literature